Vanda Pharmaceuticals Inc.

Washington, DC Doing business as Vanda

UEI
NG5JU1TQ3379
CAGE
68U09
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
2200 Pennsylvania Ave NW #300e, Washington, DC 20037, USA
Website
vandapharma.com
Founded
2003
Employees
251-1K
Estimated annual revenue
$100M-$250M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Vanda Pharmaceuticals Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Pharm - hetlioz Contract · 36C26026F0025 Veterans Integrated Service Network 20 $26,344
Hetlioz - bulk Contract · 36C26025F0002 Veterans Integrated Service Network 20 $131,068
Pharmaceutical Contract · 36C26024F0173 Veterans Integrated Service Network 20 $154,049
Hetlioz 20MG capsule Contract · 36C26023F0431 Veterans Integrated Service Network 20 $77,799
Tasimelteon 20MG cap (hetlioz) Contract · 36C25222F0228 Veterans Integrated Service Network 12 $32,891

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc., headquartered in Washington, DC, is a for-profit corporate entity registered in SAM.gov since 2011 and specializing in pharmaceutical manufacturing. The company is a global biopharmaceutical manufacturer primarily focused on developing and producing specialized pharmaceutical products, with a particular emphasis on HETLIOZ (tasimelteon), a medication used to treat Non-24-Hour Sleep-Wake Disorder in blind adults and patients with Smith-Magenis Syndrome. As a pharmaceutical manufacturer, Vanda provides specialized medical products to federal agencies, with a significant portion of its federal contract work concentrated within the U.S. Department of Veterans Affairs (VA).

Through its federal contract awards, Vanda has consistently provided pharmaceutical products, specifically HETLIOZ 20MG capsules, to various Veterans Integrated Service Networks (VISNs), including VISN 12 and VISN 20. The company's contract awards are not designated as set-asides and are primarily delivered through Delivery Order and Blanket Purchase Agreement (BPA) contracts under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB). The contract values have ranged from approximately $32,000 to $171,234, with contract periods typically spanning one year. Each contract supports the VA's efforts to provide specialized pharmaceutical products to eligible veterans, addressing unique medical needs through targeted medication solutions.

Vanda holds multiple federal contract Indefinite Delivery Vehicles (IDVs), including a multiple-award Federal Supply Schedule contract with a $16,131,060 ceiling value through August 31, 2029, and two single-award Blanket Purchase Agreements with ceiling values of $3,753,465 and $3,069,780. These IDVs are primarily awarded by the VA National Acquisition Center and Veterans Integrated Service Networks, specifically covering drugs, pharmaceuticals, and hematology-related products. The contracts provide a streamlined procurement mechanism for VA agencies to order HETLIOZ, demonstrating Vanda's critical role as a key supplier of specialized pharmaceutical products to federal healthcare systems, particularly for veterans with specific medical conditions requiring targeted pharmaceutical interventions.

Contract vehicles

Quick answers

What is Vanda Pharmaceuticals Inc.'s UEI?

Vanda Pharmaceuticals Inc.'s Unique Entity ID (UEI) in SAM.gov is NG5JU1TQ3379.

What is Vanda Pharmaceuticals Inc.'s CAGE code?

Vanda Pharmaceuticals Inc.'s CAGE code is 68U09.

What is Vanda Pharmaceuticals Inc.'s primary NAICS code?

Vanda Pharmaceuticals Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Vanda Pharmaceuticals Inc. located?

Vanda Pharmaceuticals Inc.'s physical address in SAM.gov is 2200 Pennsylvania Ave NW #300e, Washington, DC 20037, USA.

Is Vanda Pharmaceuticals Inc. registered in SAM.gov?

Yes. Vanda Pharmaceuticals Inc.'s SAM.gov registration is active through July 26, 2027.

Which contract vehicles does Vanda Pharmaceuticals Inc. hold?

Vanda Pharmaceuticals Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.

What is Vanda Pharmaceuticals Inc.'s most recent federal award?

Vanda Pharmaceuticals Inc.'s most recent federal contract award is Pharm - hetlioz (36C26026F0025), from Veterans Integrated Service Network 20, on October 1, 2025.

On GovTribe

See Vanda Pharmaceuticals Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors